News
Fintel on MSN12h
Barclays Downgrades Sarepta Therapeutics (SRPT)Fintel reports that on July 27, 2025, Barclays downgraded their outlook for Sarepta Therapeutics (NasdaqGS:SRPT) from ...
Fintel on MSN12h
Barclays Upgrades Sarepta Therapeutics (SRPT)Fintel reports that on July 30, 2025, Barclays upgraded their outlook for Sarepta Therapeutics (NasdaqGS:SRPT) from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback